Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
13.82
+0.10 (0.73%)
At close: Sep 17, 2026, 4:00 PM EDT
13.57
-0.25 (-1.83%)
After-hours: Sep 17, 2026, 7:30 PM EDT

Turn Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
412116---
Market Cap Growth
-----
Enterprise Value
408113---
Last Close Price
13.823.94---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
599.3324.75---
P/TBV Ratio
-30.82---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
8.910.02-0.680.290.07
Net Debt / Equity Ratio
-6.07-1.074.24-13.48-1.75
Net Debt / EBITDA Ratio
0.490.790.430.510.49
Quick Ratio
1.170.851.232.411.22
Current Ratio
1.190.871.552.451.23
Return on Equity (ROE)
-686.28%-141.67%--369.43%-
Return on Assets (ROA)
-50.27%-55.90%-55.30%-58.56%-
Return on Capital Employed (ROCE)
-104.50%-103.20%-134.00%-151.50%-353.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-2.05%-2.75%---
Buyback Yield / Dilution
-7.08%-4.03%-0.56%--
SEC Filings: 10-K · 10-Q